Cover Image
市場調查報告書

呼吸窘迫症候群:全球臨床實驗趨勢

Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2015

出版商 GlobalData 商品編碼 229132
出版日期 內容資訊 英文 87 Pages
訂單完成後即時交付
價格
Back to Top
呼吸窘迫症候群:全球臨床實驗趨勢 Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2015
出版日期: 2015年07月15日 內容資訊: 英文 87 Pages
簡介

本報告提供呼吸窘迫症候群臨床實驗相關之最新趨勢分析,提供您各地區的臨床實驗數量,臨床實驗的各階段進展,受驗對象採用狀況,有潛力的贊助商,各企業和研究機關的研究進展,有潛力的藥劑比較等資訊。

簡介

  • 呼吸窘迫症候群
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲的主要5個國家臨床實驗數量
    • 中南美的主要5個國家臨床實驗數量

G7各國臨床實驗數量:呼吸系統疾病治療藥臨床實驗上呼吸窘迫症候群的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:呼吸系統疾病治療藥臨床實驗上呼吸窘迫症候群的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標的達成情形

未完成的臨床實驗數量

一定期間所採用的受驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

呼吸窘迫症候群治療藥臨床實驗主要的參與企業

有潛力的藥劑

最新臨床實驗新聞

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Discovery Laboratories, Inc.
    • Chiesi Farmaceutici SpA
    • Ikaria Holdings, Inc.
    • GlaxoSmithKline Plc
    • Serendex Pharmaceuticals A/S
    • Pierrel S.p.A.
    • Forest Laboratories, Inc. (Inactive)
    • F. Hoffmann-La Roche Ltd.
    • Abbott Laboratories
    • Actelion Ltd
  • 有代表性的研究機關·醫院臨床實驗概要
    • National Heart, Lung, and Blood Institute
    • Tabriz University of Medical Sciences
    • Eunice Kennedy Shriver National Institute of Child Health and Human Development
    • University of Oklahoma
    • Aga Khan University
    • Asan Medical Center
    • Assistance Publique Hopitaux De Marseille
    • Auckland City Hospital
    • Centre Hospitalier Universitaire de Clermont-Ferrand
    • Dr. Sami Ulus Children's Hospital

5個有代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2776CTIDB

GlobalData's clinical trial report, "Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2015" provides an overview of Respiratory Distress Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Respiratory Distress Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Respiratory Distress Syndrome
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Respiratory Distress Syndrome to Respiratory Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Respiratory Distress Syndrome to Respiratory Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Respiratory Distress Syndrome
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Respiratory Distress Syndrome Therapeutics Clinical Trials
  • Prominent Drugs
    • Latest Clinical Trials News on Respiratory Distress Syndrome
      • May 14, 2015: Discovery Labs Announces Results of Phase 2a Clinical Trial of AEROSURF
      • Apr 29, 2015: Serendex Initiates Phase I Clinical Trial For Lead Candidate Drug, Molgradex
      • Apr 16, 2015: Discovery Labs Completes Enrollment of AEROSURF Phase 2a Clinical Trial and Restructures its Business to Focus on Development of AEROSURF and Aerosolized KL4 Surfactant Pipeline
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Discovery Laboratories, Inc.
      • Clinical Trial Overview of Discovery Laboratories, Inc.
      • Chiesi Farmaceutici SpA
      • Clinical Trial Overview of Chiesi Farmaceutici SpA
      • Ikaria Holdings, Inc.
      • Clinical Trial Overview of Ikaria Holdings, Inc.
      • GlaxoSmithKline Plc
      • Clinical Trial Overview of GlaxoSmithKline Plc
      • Serendex Pharmaceuticals A/S
      • Clinical Trial Overview of Serendex Pharmaceuticals A/S
      • Pierrel S.p.A.
      • Clinical Trial Overview of Pierrel S.p.A.
      • Forest Laboratories, Inc. (Inactive)
      • Clinical Trial Overview of Forest Laboratories, Inc. (Inactive)
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Abbott Laboratories
      • Clinical Trial Overview of Abbott Laboratories
      • Actelion Ltd
      • Clinical Trial Overview of Actelion Ltd
    • Clinical Trial Overview of Top Institutes / Government
      • National Heart, Lung, and Blood Institute
      • Clinical Trial Overview of National Heart, Lung, and Blood Institute
      • Tabriz University of Medical Sciences
      • Clinical Trial Overview of Tabriz University of Medical Sciences
      • Eunice Kennedy Shriver National Institute of Child Health and Human Development
      • Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development
      • University of Oklahoma
      • Clinical Trial Overview of University of Oklahoma
      • Aga Khan University
      • Clinical Trial Overview of Aga Khan University
      • Asan Medical Center
      • Clinical Trial Overview of Asan Medical Center
      • Assistance Publique Hopitaux De Marseille
      • Clinical Trial Overview of Assistance Publique Hopitaux De Marseille
      • Auckland City Hospital
      • Clinical Trial Overview of Auckland City Hospital
      • Centre Hospitalier Universitaire de Clermont-Ferrand
      • Clinical Trial Overview of Centre Hospitalier Universitaire de Clermont-Ferrand
      • Dr. Sami Ulus Children's Hospital
      • Clinical Trial Overview of Dr. Sami Ulus Children's Hospital
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials by Region, 2015*
  • Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015*
  • Proportion of Respiratory Distress Syndrome to Respiratory Clinical Trials, G7 Countries (%), 2015*
  • Respiratory Distress Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Respiratory Distress Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Respiratory Distress Syndrome to Respiratory Clinical Trials, E7 Countries (%), 2015*
  • Respiratory Distress Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Respiratory Distress Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Respiratory Distress Syndrome Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Respiratory Distress Syndrome Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Respiratory Distress Syndrome Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Respiratory Distress Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Discovery Laboratories, Inc., 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiesi Farmaceutici SpA, 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Ikaria Holdings, Inc., 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Serendex Pharmaceuticals A/S, 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Pierrel S.p.A., 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Forest Laboratories, Inc. (Inactive), 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Tabriz University of Medical Sciences, 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oklahoma, 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Aga Khan University, 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique Hopitaux De Marseille, 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Auckland City Hospital, 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Clermont-Ferrand, 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Sami Ulus Children's Hospital, 2015*

List of Figures

  • Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015*
  • Proportion of Respiratory Distress Syndrome to Respiratory Clinical Trials, G7 Countries (%), 2015*
  • Respiratory Distress Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Respiratory Distress Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Respiratory Distress Syndrome to Respiratory Clinical Trials, E7 Countries (%), 2015*
  • Respiratory Distress Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Respiratory Distress Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Respiratory Distress Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top